Famotidine Powder, For Suspension
Product Images NDC 0832-6045

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 0832-6045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Famotidine 01)

Chemical structure of Famotidine, showing its arrangement of atoms and bonds including sulfur, nitrogen, and other elements characteristic of the molecule.*

FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Label for Famotidine oral suspension, USP 40 mg/5 mL powder for suspension, 50 mL reconstituted bottle. It contains 400 mg famotidine total, for oral use only, requiring shaking before each use. Distributed by Upsher-Smith Laboratories, LLC, with directions for reconstitution and storage instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.